Karthik Radhakrishnan - Jul 1, 2024 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Chief Financial Officer
Signature
/s/ Karthik Radhakrishnan
Stock symbol
MNPR
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
4
Date filed
7/3/2024, 06:22 PM
Next filing
Oct 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +125K $0.00 125K Jul 1, 2024 Commom Stock 125K $0.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 1, 2024, the reporting person was granted 125,000 stock options, vesting 6/48ths (15,625 shares) on December 31, 2024, and 1/48th every month thereafter until the stock option is fully vested on July 1, 2028.